# Ankyra Therapeutics, Inc. — Form D

Ankyra Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-09. The offering totals $45.0M, of which $45.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-09-09
- Form: D
- Accession: 0001811511-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $45.0M
- Amount sold: $45.0M
- Investors: 14
- Date of first sale: 2021-08-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-412827

## Issuer

- Name: Ankyra Therapeutics, Inc.
- CIK: 0001811511
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 83 NEWBURY STREET, BOSTON, MA, 02116
- Phone: 617-823-2399

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Philip Ferneau | Director | Hanover, NH |
| Tillman Gerngross | Director | Waltham, MA |
| Terrance McGuire | Director | Cambridge, MA |
| Ajay Royan | Director | Leawood, KS |
| Tillman Gerngross | Executive Officer | Waltham, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-05-15](https://search.stillhousedata.com/formd/0001811511-20-000001) | D | $14.5M | $14.5M |

## More

- [CIK 1811511 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1811511&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001811511-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.